Daniel Brat
#71,875
Most Influential Person Now
American neuropathologist
Daniel Brat's AcademicInfluence.com Rankings
Daniel Bratmedical Degrees
Medical
#1276
World Rank
#1599
Historical Rank
Neurology
#190
World Rank
#263
Historical Rank
Download Badge
Medical
Daniel Brat's Degrees
- Doctorate Medicine University of Chicago
- PhD Neurobiology University of Chicago
Why Is Daniel Brat Influential?
(Suggest an Edit or Addition)According to Wikipedia, Daniel Jay Brat is an American neuropathologist and brain tumor investigator. He is the Magerstadt Professor and Chair of Pathology at Northwestern University Feinberg School of Medicine and Northwestern Memorial Healthcare.
Daniel Brat's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways (2008) (5775)
- The Immune Landscape of Cancer (2018) (2766)
- The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. (2021) (2388)
- Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. (2015) (2211)
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) (1646)
- Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma (2016) (1474)
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) (1360)
- The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. (2005) (682)
- Transforming Fusions of FGFR and TACC Genes in Human Glioblastoma (2012) (647)
- Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. (2005) (593)
- Predicting cancer outcomes from histology and genomics using convolutional networks (2017) (563)
- International Society of Neuropathology‐Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading (2014) (514)
- Pathogenic Germline Variants in 10,389 Adult Cancers (2018) (501)
- 'Pseudopalisading' Necrosis in Glioblastoma: A Familiar Morphologic Feature That Links Vascular Pathology, Hypoxia, and Angiogenesis (2006) (496)
- Microregional extracellular matrix heterogeneity in brain modulates glioma cell invasion. (2004) (495)
- cIMPACT-NOW update 3: recommended diagnostic criteria for “Diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV” (2018) (492)
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) (471)
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups (2011) (461)
- Notch1 and Notch2 Have Opposite Effects on Embryonal Brain Tumor Growth (2004) (417)
- Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population (2004) (408)
- MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. (2013) (370)
- Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution (2015) (307)
- Progression of pancreatic intraductal neoplasias to infiltrating adenocarcinoma of the pancreas. (1998) (304)
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group. (2011) (303)
- Discovery of a Proneurogenic, Neuroprotective Chemical (2010) (297)
- cIMPACT‐NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT‐Utrecht meeting on future CNS tumor classification and grading (2020) (293)
- Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma (2004) (293)
- Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes. (1999) (292)
- Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. (2014) (290)
- Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology (2016) (256)
- cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas (2020) (253)
- Pleomorphic xanthoastrocytoma (1999) (253)
- PTEN and hypoxia regulate tissue factor expression and plasma coagulation by glioblastoma. (2005) (226)
- LONGITUDINAL MOLECULAR TRAJECTORIES OF DIFFUSE GLIOMA IN ADULTS (2019) (223)
- Primary melanocytic neoplasms of the central nervous systems. (1999) (214)
- T2–FLAIR Mismatch, an Imaging Biomarker for IDH and 1p/19q Status in Lower-grade Gliomas: A TCGA/TCIA Project (2017) (209)
- The contribution of protease-activated receptor 1 to neuronal damage caused by transient focal cerebral ischemia (2003) (202)
- Pituicytoma: a distinctive low-grade glioma of the neurohypophysis. (2000) (196)
- The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. (2012) (194)
- Extraventricular Neurocytomas: Pathologic Features and Clinical Outcome (2001) (189)
- 6-phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumor growth by inhibiting LKB1-AMPK signaling (2014) (189)
- Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context (2018) (188)
- Vasculostatin, a proteolytic fragment of Brain Angiogenesis Inhibitor 1, is an antiangiogenic and antitumorigenic factor (2005) (170)
- Third Ventricular Chordoid Glioma: A Distinct Clinicopathologic Entity (1997) (166)
- Tumor-Infiltrating Lymphocytes in Glioblastoma Are Associated with Specific Genomic Alterations and Related to Transcriptional Class (2013) (164)
- Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. (2001) (163)
- Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models (2017) (157)
- Protease-activated receptor-1 in human brain: localization and functional expression in astrocytes (2004) (156)
- Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses. (2007) (155)
- The neuronal PAS domain protein 3 transcription factor controls FGF-mediated adult hippocampal neurogenesis in mice. (2005) (150)
- Genetic and hypoxic regulation of angiogenesis in gliomas (2004) (149)
- Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. (2010) (149)
- Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression. (2011) (149)
- IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group (2010) (147)
- Newly Codified Glial Neoplasms of the 2007 WHO Classification of Tumours of the Central Nervous System: Angiocentric Glioma, Pilomyxoid Astrocytoma and Pituicytoma (2007) (146)
- Glomeruloid microvascular proliferation orchestrated by VPF/VEGF: a new world of angiogenesis research. (2001) (144)
- Primary central nervous system posttransplant lymphoproliferative disorders. (2004) (143)
- Practical Surgical Neuropathology: A Diagnostic Approach (2010) (142)
- Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy (2015) (138)
- The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas (2010) (136)
- Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. (2001) (136)
- Wild-type microglia do not reverse pathology in mouse models of Rett syndrome (2015) (134)
- Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. (2013) (129)
- Astroblastoma: Clinicopathologic Features and Chromosomal Abnormalities Defined by Comparative Genomic Hybridization (2000) (128)
- Surgical neuropathology update: a review of changes introduced by the WHO classification of tumours of the central nervous system, 4th edition. (2008) (127)
- The role of radiotherapy in the management of progressive glioblastoma : a systematic review and evidence-based clinical practice guideline. (2014) (126)
- Research and applications: Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data (2013) (124)
- Malignant Glioma Physiology: Cellular Response to Hypoxia and Its Role in Tumor Progression (2003) (123)
- Pediatric Neuroblastic Brain Tumors Containing Abundant Neuropil and True Rosettes (2000) (123)
- Ancillary FISH analysis for 1p and 19q status: preliminary observations in 287 gliomas and oligodendroglioma mimics. (2003) (121)
- Epidermal growth factor receptor and PTEN modulate tissue factor expression in glioblastoma through JunD/activator protein-1 transcriptional activity. (2009) (120)
- Vasculostatin inhibits intracranial glioma growth and negatively regulates in vivo angiogenesis through a CD36-dependent mechanism. (2009) (114)
- Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling. (2015) (112)
- Molecular genetic alterations in radiation-induced astrocytomas. (1999) (110)
- Aberrant methylation and down-regulation of TMS1/ASC in human glioblastoma. (2004) (109)
- Announcing cIMPACT-NOW: the Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (2016) (109)
- Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission. (2000) (107)
- Brain angiogenesis inhibitor 1 is differentially expressed in normal brain and glioblastoma independently of p53 expression. (2003) (104)
- Targeted cancer gene therapy using a hypoxia inducible factor dependent oncolytic adenovirus armed with interleukin-4. (2007) (104)
- Glioma through the looking GLASS: molecular evolution of diffuse gliomas and the Glioma Longitudinal Analysis Consortium (2018) (102)
- Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation (2002) (102)
- Phase I and II Study of Induction Chemotherapy With Methotrexate, Rituximab, and Temozolomide, Followed By Whole-Brain Radiotherapy and Postirradiation Temozolomide for Primary CNS Lymphoma: NRG Oncology RTOG 0227. (2016) (101)
- Anti-Invasive Adjuvant Therapy with Imipramine Blue Enhances Chemotherapeutic Efficacy Against Glioma (2012) (101)
- Interstitial delivery of carboplatin via biodegradable Polymers is effective against experimental glioma in the rat (1996) (99)
- Pituicytoma: Report of Two Cases and Clues Regarding Histogenesis (2004) (97)
- Diagnosis of malignant glioma: role of neuropathology (2008) (96)
- Machine-Based Morphologic Analysis of Glioblastoma Using Whole-Slide Pathology Images Uncovers Clinically Relevant Molecular Correlates (2013) (96)
- Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma: a report of the Children's Oncology Group ACNS0423 study. (2016) (95)
- Lysine acetylation activates 6-phosphogluconate dehydrogenase to promote tumor growth. (2014) (95)
- Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. (2006) (94)
- Molecular genetics of gliomas. (2014) (94)
- Integrated morphologic analysis for the identification and characterization of disease subtypes (2012) (94)
- Controlled Local Delivery of Interleukin-2 by Biodegradable Polymers Protects Animals from Experimental Brain Tumors and Liver Tumors (2001) (93)
- The descriptive epidemiology of atypical teratoid/rhabdoid tumors in the United States, 2001-2010. (2014) (93)
- Akt phosphorylation regulates the tumour-suppressor merlin through ubiquitination and degradation (2007) (90)
- PDGFRA Amplification is Common in Pediatric and Adult High‐Grade Astrocytomas and Identifies a Poor Prognostic Group in IDH1 Mutant Glioblastoma (2013) (88)
- Cancer susceptibility variants and the risk of adult glioma in a US case–control study (2011) (88)
- Chordoid glioma: a neoplasm unique to the hypothalamus and anterior third ventricle. (2001) (86)
- Genetic Markers in Glioblastoma: Prognostic Significance and Future Therapeutic Implications: On: Impact of Genotype Morphology on the Prognosis of Glioblastoma. Schmidt MC Antweiler S, Urban N, et al. J Neuropathol Exp Neurol 2002;61:321–328. (2003) (84)
- Distinguishing Chordoid Meningiomas From Their Histologic Mimics: An Immunohistochemical Evaluation (2009) (83)
- Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. (2002) (83)
- Human Brat ortholog TRIM3 is a tumor suppressor that regulates asymmetric cell division in glioblastoma. (2014) (82)
- Molecular Subtypes of Glioblastoma Are Relevant to Lower Grade Glioma (2014) (81)
- Anaplastic meningioma versus meningeal hemangiopericytoma: immunohistochemical and genetic markers. (2004) (79)
- Antitumor effect of 2-methoxyestradiol in a rat orthotopic brain tumor model. (2006) (79)
- Genetic modulation of hypoxia induced gene expression and angiogenesis: relevance to brain tumors. (2003) (73)
- A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma (2018) (73)
- hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. (2003) (71)
- Infiltrative Astrocytomas With Granular Cell Features (Granular Cell Astrocytomas): A Study of Histopathologic Features, Grading, and Outcome (2002) (71)
- Differential expression of folate receptor in pituitary adenomas. (2003) (71)
- Biomarker-driven diagnosis of diffuse gliomas. (2015) (71)
- A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma (2021) (71)
- Clarifying the diffuse gliomas: an update on the morphologic features and markers that discriminate oligodendroglioma from astrocytoma. (2005) (71)
- Tuberous sclerosis-associated lesions of the kidney, brain, and skin are angiogenic neoplasms. (2002) (70)
- Local delivery of chemotherapy and concurrent external beam radiotherapy prolongs survival in metastatic brain tumor models. (1996) (68)
- Human BRE1 is an E3 ubiquitin ligase for Ebp1 tumor suppressor. (2008) (68)
- RESEARCH ARTICLE: Intravascular Thrombosis in Central Nervous System Malignancies: A Potential Role in Astrocytoma Progression to Glioblastoma (2007) (67)
- Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors (2004) (67)
- An Integrative Approach for In Silico Glioma Research (2010) (65)
- Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis (2015) (65)
- Dysembryoplastic Neuroepithelial Tumor-Like Neoplasm of the Septum Pellucidum: A Lesion Often Misdiagnosed as Glioma: Report of 10 Cases (2001) (64)
- Paracrine delivery of IL-12 against intracranial 9L gliosarcoma in rats. (2000) (63)
- cIMPACT‐NOW (the consortium to inform molecular and practical approaches to CNS tumor taxonomy): a new initiative in advancing nervous system tumor classification (2017) (62)
- Intrasellar pituicytoma in a patient with other endocrine neoplasms. (2001) (62)
- Diffuse Leptomeningeal Neuroepithelial Tumor: 9 Pediatric Cases With Chromosome 1p/19q Deletion Status and IDH1 (R132H) Immunohistochemistry (2013) (60)
- Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials. (2004) (60)
- Fatal West Nile virus encephalitis in a renal transplant recipient. (2004) (58)
- A data model and database for high-resolution pathology analytical image informatics (2011) (58)
- Paracrine immunotherapy with interleukin-2 and local chemotherapy is synergistic in the treatment of experimental brain tumors. (1999) (58)
- Integrative, Multimodal Analysis of Glioblastoma Using TCGA Molecular Data, Pathology Images, and Clinical Outcomes (2011) (58)
- Glioma progression is shaped by genetic evolution and microenvironment interactions (2022) (56)
- A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle (2018) (55)
- Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers (2006) (55)
- Extraneural metastatic glioblastoma after interstitial brachytherapy. (2000) (54)
- cIMPACT‐NOW: a practical summary of diagnostic points from Round 1 updates (2019) (53)
- Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors (2019) (53)
- Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma (2010) (52)
- Glioblastoma with Oligodendroglioma Component (GBM‐O): Molecular Genetic and Clinical Characteristics (2013) (52)
- Congenital Glioblastoma: A Clinicopathologic and Genetic Analysis (2007) (51)
- Effect of cisplatin and ACTH4–9 on neural transport in cisplatin induced neurotoxicity (1995) (50)
- Differential Expression between Pilocytic and Anaplastic Astrocytomas: Identification of Apolipoprotein D as a Marker for Low‐Grade, Non‐Infiltrating Primary CNS Neoplasms (2002) (50)
- Cancer stem cell division: when the rules of asymmetry are broken. (2015) (50)
- Diagnostic implications of IDH1-R132H and OLIG2 expression patterns in rare and challenging glioblastoma variants (2013) (50)
- Novel genotype-phenotype associations in human cancers enabled by advanced molecular platforms and computational analysis of whole slide images (2014) (48)
- (−)-P7C3-S243 Protects a Rat Model of Alzheimer’s Disease From Neuropsychiatric Deficits and Neurodegeneration Without Altering Amyloid Deposition or Reactive Glia (2017) (48)
- Management of patients with recurrence of diffuse low grade glioma (2015) (48)
- Management of newly diagnosed glioblastoma: guidelines development, value and application (2009) (48)
- The Neuropsychiatric Disease-Associated Gene cacna1c Mediates Survival of Young Hippocampal Neurons123 (2016) (48)
- Transgenic Expression of Dominant Negative Tuberin through a Strong Constitutive Promoter Results in a Tissue-specific Tuberous Sclerosis Phenotype in the Skin and Brain* (2005) (47)
- Digital Pathology: Data-Intensive Frontier in Medical Imaging (2012) (47)
- Analysis of graft survival in a trial of stem cell transplant in ALS (2014) (46)
- Silent corticotroph adenomas: Emory University cohort and comparison with ACTH-negative nonfunctioning pituitary adenomas. (2012) (45)
- Interactive phenotyping of large-scale histology imaging data with HistomicsML (2017) (45)
- TRIM8 regulates stemness in glioblastoma through PIAS3‐STAT3 (2017) (44)
- Attractin Is Elevated in the Cerebrospinal Fluid of Patients with Malignant Astrocytoma and Mediates Glioma Cell Migration (2006) (44)
- Emulsifier for intravenous cyclosporin inhibits neurite outgrowth, causes deficits in rapid axonal transport and leads to structural abnormalities in differentiating N1E.115 neuroblastoma. (1992) (43)
- Magnetic Resonance Imaging Features of Pituicytomas: Analysis of 10 Cases (2010) (43)
- P14ARF inhibits human glioblastoma-induced angiogenesis by upregulating the expression of TIMP3. (2012) (42)
- The impact of histopathology and NAB2–STAT6 fusion subtype in classification and grading of meningeal solitary fibrous tumor/hemangiopericytoma (2018) (42)
- Drosophila Brat and Human Ortholog TRIM3 Maintain Stem Cell Equilibrium and Suppress Brain Tumorigenesis by Attenuating Notch Nuclear Transport. (2016) (42)
- Tuberous sclerosis complex suppression in cerebellar development and medulloblastoma: separate regulation of mammalian target of rapamycin activity and p27 Kip1 localization. (2009) (40)
- Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group (2010) (39)
- Pediatric Chordoid Glioma with Chondroid Metaplasia (2001) (38)
- Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. (2001) (38)
- Reactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases. (2013) (37)
- Chronic meningitis with cranial neuropathies in Wegener's granulomatosis. Case report and review of the literature. (1997) (37)
- Metastasis infiltration: an investigation of the postoperative brain-tumor interface. (2011) (37)
- Microphthalmia transcription factor immunohistochemistry: a useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. (2001) (37)
- Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004–2012, varying) (2016) (36)
- Differential neuronal localizations and dynamics of phosphorylated and unphosphorylated type 1 inositol 1,4,5-trisphosphate receptors (2001) (36)
- Best cases from the AFIP: glioblastoma multiforme. (2007) (35)
- Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth. (2003) (35)
- How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens? (1999) (34)
- [18F]Fluciclovine PET discrimination between high- and low-grade gliomas (2018) (34)
- Alterations in molecular pathways of diffusely infiltrating glial neoplasms: application to tumor classification and anti-tumor therapy (Review). (2003) (33)
- Granular Cell Astrocytomas Show a High Frequency of Allelic Loss but are not a Genetically Defined Subset (2003) (32)
- The medical necessity of advanced molecular testing in the diagnosis and treatment of brain tumor patients. (2019) (32)
- The structural basis of molecular genetic deletions. An integration of classical cytogenetic and molecular analyses in pancreatic adenocarcinoma. (1997) (31)
- CDK5 Inhibition Resolves PKA/cAMP-Independent Activation of CREB1 Signaling in Glioma Stem Cells (2018) (30)
- Acrylamide and Glycidamide Impair Neurite Outgrowth in Differentiating N1E.115 Neuroblastoma Without Disturbing Rapid Bidirectional Transport of Organelles Observed by Video Microscopy (1993) (30)
- Oncogenic regulation of tissue factor and thrombosis in cancer. (2012) (30)
- Spinal intradural clear cell meningioma following resection of a suprasellar clear cell meningioma. Case report and recommendations for management. (2005) (30)
- Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups (2016) (29)
- Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease (2019) (29)
- Silencing of TMS1/ASC promotes resistance to anoikis in breast epithelial cells. (2009) (29)
- Special lecture: glial reactivity after damage: implications for scar formation and neuronal recovery. (2005) (29)
- Tau‐associated neuropathology in ganglion cell tumours increases with patient age but appears unrelated to ApoE genotype (2001) (29)
- Lectins identify glycan biomarkers on glioblastoma-derived cancer stem cells. (2012) (28)
- Multi-faceted computational assessment of risk and progression in oligodendroglioma implicates NOTCH and PI3K pathways (2018) (28)
- Mismatch repair deficiency is an uncommon mechanism of alkylator resistance in pediatric malignant gliomas: A report from the children's oncology group (2010) (28)
- Chordoid Glioma: A Case Report and Molecular Characterization of Five Cases (2009) (28)
- Automated cell segmentation with 3D fluorescence microscopy images (2015) (28)
- Erratum: Targeted cancer gene therapy using a hypoxia inducible factor-dependent oncolytic adenovirus armed with interleukin-4 (Cancer Research (2007) 67, (6872-6881)) (2007) (27)
- Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop. (2014) (27)
- Blockade of Glioma Proliferation Through Allosteric Inhibition of JAK2 (2013) (27)
- Incorporating Advances in Molecular Pathology Into Brain Tumor Diagnostics (2018) (26)
- Texture based image recognition in microscopy images of diffuse gliomas with multi-class gentle boosting mechanism (2010) (26)
- Erratum: Depletion of peripheral macrophages and brain microglia increases brain tumor titers of oncolytic viruses (Cancer Research (2007) 67, (9398-9406)) (2007) (25)
- Fyn-phosphorylated PIKE-A binds and inhibits AMPK signaling, blocking its tumor suppressive activity (2015) (24)
- Meningioangiomatosis: A Case Report and Literature Review Emphasizing Diverse Appearance on Different Imaging Modalities (2011) (24)
- Accuracy of grading gliomas on CT‐guided stereotactic biopsies: A survival analysis (1997) (23)
- Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004–2011 (2015) (23)
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence (2011) (23)
- A high-performance spatial database based approach for pathology imaging algorithm evaluation (2013) (23)
- Morphological signatures and genomic correlates in glioblastoma (2011) (22)
- TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics (2017) (22)
- Phase I analysis of BCNU-impregnated biodegradable polymer wafers followed by systemic interferon alfa-2b in adults with recurrent glioblastoma multiforme (2008) (22)
- Proliferation (MIB-1 Expression) in Oligodendrogliomas: Assessment of Quantitative Methods and Prognostic Significance (2006) (21)
- Pediatric Chordoid Glioma withChondroid Metaplasia (2001) (21)
- 9p21 and 13q14 dosages in ependymomas. A clinicopathologic study of 101 cases (2004) (21)
- Tumours: introduction and neuroepithelial tumours (2008) (21)
- Glioblastoma: biology, genetics, and behavior. (2012) (21)
- Towards building computerized image analysis framework for nucleus discrimination in microscopy images of diffuse glioma (2011) (21)
- Galectin-3 Expression is Ubiquitous in Tumors of the Sellar Region, Nervous System, and Mimics: An Immunohistochemical and RT-PCR Study (2008) (20)
- Co-amplification of Phosphoinositide 3-kinase enhancer A and Cyclin-dependent kinase 4 Triggers Glioblastoma Progression (2017) (19)
- Genomic profiling of lower-grade gliomas uncovers cohesive disease groups: implications for diagnosis and treatment (2016) (18)
- Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy. (2014) (18)
- Dynamic registration for gigapixel serial whole slide images (2017) (18)
- Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014. (2019) (18)
- Data Sets for the Reporting of Tumors of the Central Nervous System. (2019) (18)
- Surfen‐mediated blockade of extratumoral chondroitin sulfate glycosaminoglycans inhibits glioblastoma invasion (2019) (17)
- Upregulation of hypoxia inducible factor is associated with attenuation of neuronal injury in neonatal piglets undergoing deep hypothermic circulatory arrest. (2005) (17)
- 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins (2017) (17)
- AN ASTROBLASTOMA MIMICKING A CAVERNOUS MALFORMATION: CASE REPORT (2007) (17)
- P53 tumor suppression network in cancer epigenetics. (2015) (16)
- TNFRSF10C copy number variation is associated with metastatic colorectal cancer. (2016) (16)
- ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma (2021) (16)
- A comprehensive framework for classification of nuclei in digital microscopy imaging: An application to diffuse gliomas (2011) (16)
- Hypoxia-inducible factors individually facilitate inflammatory myeloid metabolism and inefficient cardiac repair (2021) (16)
- Molecular Biomarker Testing for the Diagnosis of Diffuse Gliomas. (2022) (15)
- Drak/STK17A Drives Neoplastic Glial Proliferation through Modulation of MRLC Signaling. (2018) (15)
- The elusive origin of chordoid glioma. (2006) (15)
- Ectopic Cerebellum Presenting as a Suprasellar Mass in Infancy: Implications for Cerebellar Development (2001) (15)
- Phase 2 study of concurrent radiotherapy and temozolomide followed by temozolomide and lomustine in the treatment of children with high-grade glioma : a report of the Children ’ s Oncology Group ACNS 0423 study (2016) (15)
- May 2003: 57-year-old-woman with acute loss of strength in her right upper extremity and slurred speech. (2003) (15)
- In silico analysis of nuclei in glioblastoma using large-scale microscopy images improves prediction of treatment response (2011) (14)
- Astrocytic and Oligodendroglial Tumors (2010) (14)
- Delivery systems and molecular targets of mechanism-based therapies for GBM (2004) (14)
- Template for Reporting Results of Biomarker Testing of Specimens From Patients With Tumors of the Central Nervous System. (2015) (14)
- Merlin sumoylation is required for its tumor suppressor activity (2014) (13)
- P14ARF suppresses tumor-induced thrombosis by regulating the tissue factor pathway. (2014) (13)
- A paradigm for examining toxicant effects on viability, structure, and axonal transport of neurons in culture (2007) (13)
- The Use of Neuroimaging to Guide the Histologic Diagnosis of Central Nervous System Lesions (2012) (13)
- Tumor Angiogenesis Therapy Using Targeted Delivery of Paclitaxel to the Vasculature of Breast Cancer Metastases (2014) (12)
- Digital and Computational Pathology: Bring the Future into Focus (2019) (12)
- Neuronal and Glioneuronal Neoplasms (2010) (12)
- What Every Neuropathologist Needs to Know: Update on cIMPACT-NOW. (2019) (11)
- Normal Brain Histopathology (2018) (11)
- Cerebral Pilocytic Astrocytoma: Distinction from Infiltrating Fibrillary Astrocytomas (1998) (11)
- Ideomotor apraxia in progressive supranuclear palsy: A case study (1999) (11)
- Pathologic Features and Clinical Outcome (2001) (11)
- Automated level set segmentation of histopathologic cells with sparse shape prior support and dynamic occlusion constraint (2017) (10)
- A Conceptual Shift in the Grading of Meningiomas (2000) (10)
- High-performance computational analysis of glioblastoma pathology images with database support identifies molecular and survival correlates (2013) (10)
- De novo germline TP53 mutation presenting with synchronous malignancies of the central nervous system (2009) (10)
- Inhibition of breast cancer metastasis to the lungs with UBS109 (2018) (10)
- Necrotic reshaping of the glioma microenvironment drives disease progression (2022) (10)
- 35‐YEAR‐OLD HIV‐POSITIVE WOMAN WITH BASAL FOREBRAIN MASS (2010) (9)
- GE-41COMPREHENSIVE AND INTEGRATIVE GENOMIC CHARACTERIZATION OF DIFFUSE LOWER GRADE GLIOMAS (2014) (9)
- Progesterone improves neurocognitive outcomes following therapeutic cranial irradiation in mice (2017) (9)
- Chordoid glioma of the third ventricle (2006) (9)
- High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and recurrent monosomy 13 (2022) (9)
- Practical Surgical Neuropathology: A Diagnostic Approach: A Volume in the Pattern Recognition Series (2010) (9)
- Molecular Biomarker-Defined Brain Tumors: Epidemiology, Validity, and Completeness in the United States. (2022) (9)
- Methods for in vitro modeling of glioma invasion: Choosing tools to meet the need (2020) (8)
- Erratum: Tuberous Sclerosis-Associated Neoplasms Express Activated p42/44 Mitogen-Activated Protein (MAP) Kinase, and Inhibition of MAP Kinase Signaling Results in Decreased in Vivo Tumor Growth (Clinical Cancer Research (August 15, 2003) 19:9 (3469-3475)) (2003) (8)
- Abstract 936: Comprehensive and integrative genomic characterization of diffuse lower grade gliomas (2014) (8)
- Practical Diagnostic Approach to the Presence of Hyphae in Neuropathology Specimens With Three Illustrative Cases (2018) (8)
- Development of a Framework for Large Scale Three-Dimensional Pathology and Biomarker Imaging and Spatial Analytics (2017) (8)
- Dysembryoplastic Neuroepithelial Tumor-Like Neoplasm of the Septum Pellucidum: A Lesion Often Misdiagnosed as Glioma (2001) (8)
- The 2021 WHO classification of central nervous system tumors: what neurologists need to know (2022) (8)
- Proceedings of the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT) Oligodendroglioma Workshop. (2019) (7)
- Clarifying the Diffuse Gliomas (2005) (7)
- Chordoid glioma of the third ventricle: report of a rapidly progressive case (2017) (7)
- EGFR and C/EBP‐β oncogenic signaling is bidirectional in human glioma and varies with the C/EBP‐β isoform (2016) (7)
- Melanocytic Neoplasms of the Central Nervous System (2010) (6)
- Clumped Nuclei Segmentation with Adjacent Point Match and Local Shape-Based Intensity Analysis in Fluorescence Microscopy Images (2018) (6)
- Robust cell segmentation for histological images of Glioblastoma (2016) (6)
- Support patient search on pathology reports with interactive online learning based data extraction (2015) (6)
- Molecular Programs Underlying Asymmetric Stem Cell Division and Their Disruption in Malignancy. (2017) (6)
- Protocol for the examination of specimens from patients with tumors of the brain/spinal cord. (2008) (6)
- The Essentials of Molecular Testing in CNS Tumors: What to Order and How to Integrate Results (2020) (6)
- Meningeal melanocytoma, neurocutaneous melanosis and primary meningeal melanoma (2006) (5)
- Defining neoplastic diseases differently: An emerging paradigm from The Cancer Genome Atlas lower-grade gliomas project (2016) (5)
- The role of neuropathology in the management of newly diagnosed glioblastoma: a systematic review and evidence-based clinical practice guideline (2020) (5)
- CLINICOPATHOLOGIC FEATURES OF ASTROBLASTOMA (1999) (5)
- Is Next-Generation Sequencing Alone Sufficient to Reliably Diagnose Gliomas? (2020) (5)
- Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline. (2022) (5)
- INTEGRATIVE GENOMIC CHARACTERIZATION OF LOWER GRADE GLIOMAS (2014) (5)
- A novel mouse model of diffuse midline glioma initiated in neonatal oligodendrocyte progenitor cells highlights cell‐of‐origin dependent effects of H3K27M (2022) (5)
- Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma : Separate Regulation of Mammalian Target of Rapamycin Activity and p 27 Kip 1 Localization (2009) (5)
- Glioblastoma occurring at the site of a previous medulloblastoma following a 5‐year remission period (2012) (5)
- Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody (2015) (5)
- Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient (2021) (4)
- Other Glial Neoplasms (2018) (4)
- The role of neuropathology in the management of progressive glioblastoma (2014) (4)
- GLIONEURONAL TUMORS WITH MALIGNANT HISTOLOGICAL FEATURES (1999) (4)
- Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis. (2021) (4)
- Vaso-occlusive Mechanisms that Intiate Hypoxia and Necrosis in Glioblastoma: The Role of Thrombosis and Tissue Factor (2009) (4)
- NEURO/MEDICAL ONCOLOGY (2013) (4)
- A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis (2022) (4)
- Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma (2016) (4)
- Effective nuclei segmentation with sparse shape prior and dynamic occlusion constraint for glioblastoma pathology images (2019) (3)
- Bone flap resorption associated with indolent Propionibacterium acnes infection after cranioplasty: case report with pathological analysis. (2020) (3)
- The recurrence of the melanotic neuroectodermal tumour of infancy: an unusual presentation of a rare tumour (2020) (3)
- Angiogenesis and Invasion (2010) (3)
- Patterns of Failure for Grade 2/3 Meningioma Treated With Reduced Margin Intensity Modulated Radiation Therapy (2013) (3)
- Chordoma of the corpus callosum: case report. (2019) (3)
- Cross-sectional survey of patients, caregivers, and physicians on diagnosis and treatment of brain metastases (2021) (3)
- The Practical Application of Emerging Technologies Influencing the Diagnosis and Care of Patients With Primary Brain Tumors. (2020) (3)
- Neuropathology Patterns and Introduction (2018) (3)
- Validation of Whole Genome Methylation Profiling Classifier for Central Nervous System Tumors. (2022) (2)
- Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions. (2022) (2)
- Molecular-Genetic Classification of Gliomas and Its Practical Application to Diagnostic Neuropathology (2017) (2)
- Analysis of morphological characteristics of IDH-mutant/wildtype brain tumors using whole-lesion phenotype analysis (2021) (2)
- Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (2)
- CDK 5 Inhibition Resolves PKA / cAMP-Independent Activation of CREB 1 Signaling in Glioma Stem Cells (2018) (2)
- Newly diagnosed enhancing lesions: Steroid initiation may impede diagnosis of lymphoma involving the central nervous system (2020) (2)
- Spatiotemporal visualization of cell membrane dynamics and protein colocalization reveals correlation between membrane dynamics and metastatic invasion (2015) (2)
- TOP2B Enzymatic Activity on Promoters and Introns Modulates Multiple Oncogenes in Human Gliomas (2019) (2)
- Large-scale microscopy imaging analytics for in silico biomedicine (2016) (2)
- Integrative, Multi-modal Analysis of Glioblastoma Using TCGA Molecular Data, Pathology Images and Clinical Outcomes (2011) (2)
- A Metastasis Caught in the Act (1996) (2)
- Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma (2022) (2)
- Fluciclovine PET discrimination between high-and low-grade gliomas (2)
- Critical Commentary to: Extraventricular Neurocytoma: Morphological and Immunohistochemical Considerations on Differential Diagnosis (2002) (2)
- Abstract 2974: Comprehensive and integrative genomic characterization of diffuse lower grade gliomas (2015) (2)
- Distant Multifocal Bony Metastasis of a Grade II Meningioma: Case Report (2016) (2)
- Corrigendum: Wild-type microglia do not reverse pathology in mouse models of Rett syndrome (2015) (1)
- Abstract 113: The TCGA proneural subtype predicts improved clinical outcome for low-grade oligodendrogliomas (2010) (1)
- FISH ANALYSIS FOR 1 p AND 19 q STATUS : PRELIMINARY OBSERVATIONS IN 287 GLIOMAS AND OLIGODENDROGLIOMA MIMICS (2002) (1)
- Genomic Analysis in the Practice of Surgical Neuropathology: The Emory Experience. (2017) (1)
- OMICS AND PROGNSTIC MARKERS (2013) (1)
- 4. Molecular characterizations of adult diffuse gliomas by the Oncoscan CNV Plus assay and next-generation sequencing (NGS) (2019) (1)
- EPEN-20. EZHIP/CATACOMB COOPERATES WITH PDGF-A AND p53 LOSS TO GENERATE A GENETICALLY ENGINEERED MOUSE MODEL FOR POSTERIOR FOSSA A EPENDYMOMA (2020) (1)
- The modern pathologist: lab data deliverer, interpreter, and diagnostician. (2014) (1)
- Publisher Correction: ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma (2022) (1)
- STMC-24. NOVEL INHIBITOR OF CDK5 SIGNALING AXIS SUPPRESSES SELF-RENEWAL PROPERTIES OF GBM STEM CELLS AND INDUCES APOPTOSIS (2016) (1)
- Intravascular thrombosis is more frequent in glioblastoma than other central nervous system malignancies (2007) (1)
- Brain Tumors Chemotherapy Is Synergistic in the Treatment of Experimental Paracrine Immunotherapy with Interleukin-2 and Local Updated (2000) (1)
- Preirradiation chemotherapy with methotrexate, rituximab, and temozolomide and post-irradiation temozolomide for primary central nervous system lymphoma: RTOG 0227 phase II study results. (2013) (1)
- Abstracts from USCAP 2021: Medical Renal Pathology (Including Renal Transplantation) (828-847) (2021) (1)
- Contemporary Diagnosis of Gliomas using Biomarkers (2016) (1)
- Local interleukin-2 delivery eradicates brain and liver tumors (1998) (1)
- Omics and Prognostic Markers (2010) (1)
- A new steerable pressure force for parametric deformable models (2011) (1)
- Spinocerebellar Ataxia Type 3: A Case Report and Literature Review. (2020) (1)
- National-level overall survival patterns for molecularly-defined diffuse glioma types in the United States. (2022) (1)
- Abstracts from USCAP 2021: Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology (910-952) (2021) (1)
- Human BRE 1 Is an E 3 Ubiquitin Ligase for Ebp 1 Tumor Suppressor (1)
- Acknowledgement of Reviewers 2012 (2013) (1)
- Mechanisms Independent − through Hypoxia-Inducible Factor-1 Expression of Tissue Factor in Glioblastoma Multiforme Early Growth Response Gene-1 Regulates Hypoxia-Induced Updated (2006) (1)
- Nondiffuse Astrocytoma Variants (2018) (1)
- 6 – Astrocytic and Oligodendroglial Tumors (2018) (1)
- A contemporary molecular view of diffuse gliomas with implications for diagnosis (2020) (1)
- RARE-08. GRADING CONSIDERATIONS FOR MENINGEAL SOLITARY FIBROUS TUMOR/HEMANGIOPERICYTOMA (2018) (1)
- Clumped Nuclei Segmentation with Adjacent Point Match and Local Shape based Intensity Analysis for Overlapped Nuclei in Fluorescence In-Situ Hybridization Images (2018) (1)
- Abstract 415: Differential expression of therapeutic targets across tumor micro-environments and at infiltrative margins in glioblastoma (2015) (1)
- An orbital mass in a 5-year-old girl. (2014) (1)
- Using proton MRSI to predict response to vorinostat treatment in recurrent GBM. (2012) (1)
- Glioblastoma With Oligodendroglioma Component: A Review of Clinical, Morphologic, and Molecular Characteristics (2013) (1)
- CS-23DEFINING THE NETWORKS AND INTERSECTION OF EGFR AMPLIFICATION AND NFKBIA DELETION IN HUMAN GLIOMA (2014) (1)
- Bilateral optic neuropathy after erythematous rash. Bilateral anterior optic neuropathy due to RMSF. (2015) (1)
- Abstracts from USCAP 2021: Pulmonary, Mediastinal, Pleural, and Peritoneal Pathology (910-952) (2021) (1)
- STEM-15. CDK5 AND NOTCH SIGNALING CROSSTALK DRIVES SELF-RENEWAL IN GSCs (2018) (0)
- Chordoid glioma further defined (2002) (0)
- Synthetic Cytokine Delivery Systems for Cancer Immunotherapy (1998) (0)
- 762 Analysis of In Vivo Gene Expression Profile of Pituitary Adenomas Using cDNA Microarrays (2000) (0)
- PDTB-28. TARGETING MEDULLOBLASTOMA WITH BENZODIAZAPINES DELIVERED USING TUNABLE BIODEGRADABLE HYDROGELS (2016) (0)
- Genomic Copy Number Complexity Correlates With Overall Survival in Glioblastoma Patients. (2016) (0)
- A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis (2022) (0)
- Erratum to: STEM-19. RESISTANCE IS FUTILE: UNDERSTANDING AND TARGETING THE CDK5-CREB1-MCL1 AXIS TO PREVENT RADIATION RESISTANCE IN GLIOMA STEM CELLS. (2021) (0)
- An integrative web-based software tool for multi-dimensional pathology whole-slide image analytics (2022) (0)
- TMIC-16. INTRATUMORAL THROMBOSIS INITIATES HYPOXIA AND NECROSIS TO DRIVE TUMOR PROGRESSION THROUGH DRAMATIC TUMOR MICROENVIRONMENTAL ALTERATION (2022) (0)
- Abstract 3897: Novel inhibitor of GBM stem cells targets unique CREB & Myc-mediated self-renewal pathways regulated by CDK5 (2017) (0)
- Abstract 142: cdk5 inhibition promotes neurogenesis while reducing self-renewal of brain tumor stem cells (2018) (0)
- Myeloid Cell-Derived Creatine in the Hypoxic Niche Promotes Glioblastoma Growth (2022) (0)
- TMOD-16. HYPOXIA RESHAPES THE GLIOBLASTOMA MICROENVIRONMENT INVOKING NECROSIS AND TRIGGERING DISEASE PROGRESSION (2021) (0)
- Clinical and neuropathologic findings in a case of posterior cortical atrophy (PCA): 41.8 (2007) (0)
- TMIC-14. HYPOXIA INDUCIBLE OLIG2 MEDIATES GLIOMA STEM CELL MIGRATION (2017) (0)
- TAMI-56. HYPOXIA-DRIVEN NECROSIS DRIVES DYNAMIC TUMOR PROGRESSION IN GLIOBLASTOMA (2020) (0)
- Acute monocular visual loss in an elderly woman: a neuro-ophthalmologic emergency. (2013) (0)
- QOLP-01. EXPERIENCES FROM PATIENT, CAREGIVER, AND PHYSICIAN SURVEYS ON DIAGNOSIS AND TREATMENT OF BRAIN METASTASES (2021) (0)
- SC-21TRIM3, A HUMAN ORTHOLOG OF DROSOPHILA BRAT, MAINTAINS ASYMMETRIC CELL DIVISION OF GLIOMA STEM CELLS BY REGULATING c-MYC AND NOTCH1 (2014) (0)
- Abstract 2257: Optical imaging guidance of tumor resection margin for head and neck cancer (2010) (0)
- Predicting clinical outcomes from large scale cancer genomic profiles with deep survival models (2017) (0)
- Toward Standardized Reporting and Databasing of Polyploid Tumors (2016) (0)
- GENO-06A PAN-GLIOMA CHARACTERIZATION OF GENOMIC, EPIGENOMIC AND TRANSCRIPTOMIC ACTIVITIES REVEALS NOVEL RELATIONSHIPS BETWEEN HISTOLOGICAL SUBTYPES AND MOLECULAR SIGNATURES (2015) (0)
- Abstracts from USCAP 2021: Neuropathology and Ophthalmic Pathology (848-862) (2021) (0)
- Abstracts from USCAP 2021: Liver Pathology (795-827) (2021) (0)
- HGG-01. A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes and promotion of the NOTCH pathway (2022) (0)
- STEM-19. RESISTANCE IS FUTILE: UNDERSTANDING AND TARGETING THE CDK5-CREB1-MCL1 AXIS TO PREVENT RADIATION RESISTANCE IN GLIOMA STEM CELLS (2019) (0)
- The brain metastasis journey: Experience from patient, caregiver, and physician surveys on diagnosis and treatment of brain metastases. (2021) (0)
- Glioma Through the Looking GLASS: the Glioma Longitudinal Analysis consortium, molecular evolution of diffuse gliomas (2017) (0)
- TMIC-17. SUBTYPE-SPECIFIC CELLULAR COMPOSITION OF THE GLIOBLASTOMA MICROENVIRONMENT (2016) (0)
- Abstract 5217: Microenvironmental influences on glioma stem cell migration (2015) (0)
- Abstracts from USCAP 2021: Pathobiology and Emerging Techniques (891-902) (2021) (0)
- Abstract 2817: GD2 CAR-T cells engineered using retroviral transduction or CRISPR editing exhibit strong cytolytic potency against glioma stem cells (2022) (0)
- Abstracts from USCAP 2021: Dermatopathology (238-270) (2021) (0)
- Abstracts from USCAP 2021: Quality and Patient Safety (953-989) (2021) (0)
- [F-18]Fluciclovine PET discrimination between high- and low-grade gliomas (0)
- Methylation of the novel apoptotic gene TMS1/ASC in human glioblastoma multiforme (2002) (0)
- Abstract LB-159: Using proton MRSI to predict response of Vorinostat treatment in recurrent GBM (2012) (0)
- Granular Cell Tumour (2007) (0)
- Off the Clock: the Non-canonical Roles of Cyclin-Dependent Kinases in Neural and Glioma Stem Cell Self-Renewal (2022) (0)
- Abstract LB-029: Signal transduction in EGFR-amplified and NFKBIA-deleted human gliomas (2015) (0)
- Abstracts from USCAP 2021: Pathobiology and Emerging Techniques (891-902) (2021) (0)
- Abstracts from USCAP 2021: Endocrine Pathology (296-310) (2021) (0)
- Impact of FACBC PET in Imaging and GTV Design of Cerebral Gliomas (2013) (0)
- EPID-26. ALIGNING THE CBTRUS HISTOLOGY GROUPS WITH 2016 WHO CLASSIFICATION OF TUMORS OF THE CENTRAL NERVOUS SYSTEM (2021) (0)
- Novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of Hoxa cluster genes and promotion of neuronal lineage (2022) (0)
- Quantum Dot Nanotechnology for Detection of Gene Product Upregulation in Cultured Glioblastoma Multiforme (GBM) Cells in Response to Hypoxia and Radiation (2005) (0)
- Occupational-like organophosphate exposure disrupts microglia and accelerates deficits in a rat model of Alzheimer’s disease (2019) (0)
- EPID-11. NATIONAL EPIDEMIOLOGY AND SURVIVAL OF ADULT-TYPE DIFFUSE GLIOMAS IN THE UNITED STATES BY IDH, 1P/19Q, MGMT, AND WHO CNS GRADE (2022) (0)
- Corrigendum to: Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States. (2022) (0)
- Analysis of Cellular Feature Differences of Astrocytomas with Distinct Mutational Profiles Using Digitized Histopathology Images (2018) (0)
- Immune checkpoint blockade in glioblastoma: from tumor heterogeneity to personalized treatment (2023) (0)
- Insight into the brain metastasis journey: Initial survey results from patients and caregivers. (2019) (0)
- Abstract 874: Genetic variation in the NOTCH stem cell signaling network in relation to risk of adult-onset glioma (2011) (0)
- RADIATION-INDUCED ASTROCYTOMAS: CLINICOPATHOLOGIC FEATURES AND MOLECULAR GENETIC ALTERATIONS (1998) (0)
- analysis of TCGA pathology data resource to support integrated in silico Cancer Digital Slide Archive : an informatics (2013) (0)
- Comparison of Genomic Coverage Using Affymetrix OncoScan Array and Illumina TruSight Tumor 170 NGS Panel for Detection of Copy Number Abnormalities in Clinical GBM Specimens (2017) (0)
- LAB-IMMUNOLOGY RESEARCH (2012) (0)
- Abstracts (1926) (0)
- PATH-33. MARKERS AND MECHANISMS OF DISEASE PROGRESSION IN IDH-MUTANT ASTROCYTOMAS (2017) (0)
- THE P53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
- Inhibition of extratumoral chondroitin sulfate glycosaminoglycans stems glioma cell invasion (2019) (0)
- Abstracts from USCAP 2021: Pancreas, Gallbladder, Ampulla, and Extra-Hepatic Biliary Tree (863-890) (2021) (0)
- Abstracts from USCAP 2021: Dermatopathology (238-270) (2021) (0)
- Abstracts from USCAP 2021: Neuropathology and Ophthalmic Pathology (848-862) (2021) (0)
- Abstracts from USCAP 2021: General Surgical Pathology (405-421) (2021) (0)
- Tumor Models (In Vivo/In Vitro) (2010) (0)
- Erratum to: DDIS-27. TARGETING ATP DOCKING AND P35/P25 BINDING OF CDK5 IN GLIOMA STEM CELLS USING SYNTHETIC INHIBITORS. (2021) (0)
- Abstract LB-50: TRIM3, the human homolog of Drosophila Brat, is a tumor suppressor that regulates asymmetric cell division (ACD) in glioblastoma stem cells (2014) (0)
- NI-15USE OF VOLUMETRIC MR SPECTROSCOPIC IMAGING AND 5-ALA FLUORESCENCE-GUIDED SURGERY FOR RESECTION OF GLIOBLASTOMA (2014) (0)
- 5-Aminolevulinic Acid Guided Sampling of Glioblastoma Microenvironments Identifies Pro-Survival Signaling at Infiltrative Margins (2017) (0)
- TMET-14. TUMOR-ASSOCIATED MYELOID CELL-DERIVED CREATINE PROMOTES GLIOBLASTOMA GROWTH IN HYPOXIC NICHES AND PSEUDOPALISADING TUMOR REGIONS (2022) (0)
- Abstracts from USCAP 2021: Head and Neck Pathology (635-663) (2021) (0)
- Abstract 912: A novel genetically engineered H3.3G34R model reveals cooperation with ATRX loss in upregulation of PRC2 target genes (2022) (0)
- TAMI-43. HYPOXIC REGULATION OF GLIOBLASTOMA TUMOR GROWTH THROUGH L(3)MBTL1 (2021) (0)
- A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricle (2018) (0)
- Abstracts from USCAP 2021: Cardiovascular Pathology (148-157) (2021) (0)
- Abstracts from USCAP 2019: Neuropathology and Ophthalmic Pathology (1621-1666) (2019) (0)
- Interactive phenotyping of large-scale histology imaging data with HistomicsML (2017) (0)
- Abstracts from USCAP 2021: General Surgical Pathology (405-421) (2021) (0)
- Abstracts from USCAP 2019: Neuropathology and Ophthalmic Pathology (1621-1666) (2019) (0)
- Integrated Systems and Technologies Metabolomic Pro fi ling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression (2011) (0)
- 1 – Neuropathology Patterns and Introduction (2010) (0)
- Abstracts from USCAP 2021: Cytopathology (158-237) (2021) (0)
- Images in clinical medicine. A metastasis caught in the act. (1996) (0)
- Clinical Laboratory Testing Practices in Diffuse Gliomas Prior to Publication of 2021 World Health Organization Classification of Central Nervous System Tumors. (2022) (0)
- DIPG-44. A GAIN OF FUNCTION Ezh2 MUTATION DELAYS DIFFUSE INTRINSIC PONTINE GLIOMA PROGRESSION (2020) (0)
- Abstract 5683: Blockade of glioma proliferation via allosteric inhibition of JAK2. (2013) (0)
- Brain and Spinal Cord (2017) (0)
- Abstracts from USCAP 2021: Bone and Soft Tissue Pathology (33-65) (2021) (0)
- EPIG-16MOST DIFFERENTIAL DNA METHYLATION CHANGES OCCUR AT CANDIDATE ENHANCER ELEMENTS FOR RECURRENT LOWER GRADE GLIOMA AND GLIOBLASTOMA (2015) (0)
- DDIS-27. TARGETING ATP DOCKING AND P35/P25 BINDING OF CDK5 IN GLIOMA STEM CELLS USING SYNTHETIC INHIBITORS (2019) (0)
- Radiation Therapy Oncology Group. Research Plan 2002-2006. Pathology Committee. (2001) (0)
- Abstract 876: Genetic variation in the voltage-gated chloride channel family members CLCN2 and CLCN3 in relation to glioma risk and outcome (2011) (0)
- 103. Formation of a ClinGen Variant Curation Expert Panel (VCEP) dedicated to Oncohistone H3 Variants in Pediatric Gliomas (2022) (0)
- TMIC-35. CROSSTALK BETWEEN TAMS AND GLIOBLASTOMA STEM-LIKE CELLS IN A HYPOXIC MICROENVIRONMENT INDUCES SENESCENCE ARREST AND ENHANCED RADIORESISTANCE (2022) (0)
- GENT-02. GENETIC ALTERATIONS ASSOCIATED WITH RADIOGRAPHIC FEATURES OF PROGRESSION OF IDH-MUTANT/1p19q CO-DELETED GLIOMAS (2016) (0)
- Erratum: Malignant glioma physiology: Cellular response to hypoxia and its role in tumor progression (Annals of Internal Medicine (2003) 138 (659-668)) (2003) (0)
- High Performance Computing for Integrative Analysis of Large Pathology Image Datasets (2012) (0)
- Tuberous Sclerosis Complex Suppression in Cerebellar Development and Medulloblastoma: Separate Regulation of Mammalian Target of Rapamycin Activity and p27 Kip1 Localization Cell, Tumor, and Stem Cell Biology (2009) (0)
- EXTH-56. TARGETING GBM WITH AN ONCOLYTIC PICORNAVIRUS SVV-001 ALONE AND IN COMBINATION WITH FRACTIONATED RADIATION IN A NOVEL PANEL OF ORTHOTOPIC PDX MODELS (2022) (0)
- Abstract 2516: TRIM8 modulates stem-like cells in glioblastoma (2016) (0)
- Abstract 1153: Hypoxic microenvironments promote stemness and enhance the directed migration of glioma stem cells (2019) (0)
- Abstract B130: The intratumoral heterogeneity of glioblastoma suggests a pivotal role for clonal evolution. (2013) (0)
- DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM (2018) (0)
- Abstract 780: Multi-omic profiling of gliomas reveals distinct DNA methylation changes at tumor recurrence (2016) (0)
- Abstract 984: Alteration of the p53 pathway is associated with subclonal tumor progression in glioblastoma (2014) (0)
- Label-free in vitro assays predict the potency of anti-disialoganglioside chimeric antigen receptor T-cell products. (2023) (0)
- TMIC-23. DIFFERENTIAL EXPRESSION OF THERAPEUTIC TARGETS ACROSS TUMOR MICROENVIRONMENTS AND AT INFILTRATIVE MARGINS IN GLIOBLASTOMA (2016) (0)
- Relationship between MR Imaging Features , Gene Expression Subtype , and Histopathologic Features of Glioblastomas (2011) (0)
- Abstracts from USCAP 2021: Endocrine Pathology (296-310) (2021) (0)
- AI-010. ACTIVATION OF THE PROTOTYPICAL SFK C-Src PROMOTES ANGIOGENESIS OF HUMAN GLIOBLASTOMA (2013) (0)
- Abstract/Case Study Review Committee for the College of American Pathologists 2017 Annual Meeting (CAP17). (2017) (0)
- Erratum to: Cancer susceptibility variants and the risk of adult glioma in a US case–control study (2011) (0)
- TMIC-21. THE ROLE OF CLEC5A ON M2-LIKE TUMOR-ASSOCIATED MACROPHAGES POLARIZATION AND DISEASE PROGRESSION IN GLIOBLASTOMA (2022) (0)
- Longitudinal molecular trajectories of diffuse glioma in adults (2019) (0)
- PDTM-13. A NOVEL DIFFUSE MIDLINE GLIOMA MODEL INITIATED IN OLIG2-EXPRESSING PROGENITORS OF THE NEONATAL BRAIN (2019) (0)
- Farewell to GBM-O: Genomic and transcriptomic profiling of glioblastoma with oligodendroglioma component reveals distinct molecular subgroups (2016) (0)
- EPID-06AGE-SPECIFIC FEATURES OF LOW AND HIGH-GRADE DIFFUSE GLIOMAS BY IDH MUTATION STATUS (2015) (0)
- Abstract 3305: Trim3, the human homolog of Drosophila brat, regulates asymmetric division in glioblastoma stem cells (2011) (0)
- Middleware Architecture Approaches for Collaborative Cancer Research (2010) (0)
- STEM-30. CDK5 INHIBITION RESOLVES PKA/cAMP-INDEPENDENT ACTIVATION OF CREB1 SIGNALING IN GLIOMA STEM CELLS (2017) (0)
- Epithelioid Pituicytoma: Expanding the Morphologic Spectrum of a Rare Neoplasm. (2020) (0)
- TASI: A software tool for spatial-temporal quantification of tumor spheroid dynamics (2018) (0)
- Abstract 2168: Longitudinal analysis of diffuse glioma reveals cell state dynamics at recurrence associated with changes in genetics and the microenvironment (2022) (0)
- Abstract LB-101: Quantitative imaging of protein expression using multiplex quantum dot immunohistochemistry (2012) (0)
- PATH-34. SOLITARY FIBROUS TUMOR: NATURAL HISTORY AND PROGNOSIS IN ACCORDANCE WITH THE WHO 2021 CLASSIFICATION OF CNS TUMORS (2022) (0)
- Abstract A52: Metabolomic profiling reveals impaired xenobiotic metabolism in bladder cancer (2010) (0)
- GE-17ALTERATION OF THE p53 PATHWAY AND ANCESTRAL PROGENITORS ARE ASSOCIATED WITH TUMOR RECURRENCE IN GLIOBLASTOMA (2014) (0)
- Cordero Antibiotic Production and Resistance Ecological Populations of Bacteria Act as Socially Cohesive Units of (2012) (0)
- Oncology and Biomarkers Summit Inhibition of breast cancer bone metastasis and pancreatic and colon cancer by synthetic curcumin analogs (2017) (0)
- Meningioma With Tyrosine-Rich Crystalloids: A Case Report and Review of the Literature (2018) (0)
- Clues to target Notch2 in medulloblastoma. (2004) (0)
- A DISTINCTIVE PEDIATRIC CNS NEUROBLASTIC TUMOR: A CLINICAL AND PATHOLOGICAL DESCRIPTION OF SIX CASES (1997) (0)
- PATH-32. BRAIN TUMOR CLASSIFICATION UPDATES FROM cIMPACT-NOW, THE CONSORTIUM TO INFORM MOLECULAR AND PRACTICAL APPROACHES TO CNS TUMOR CLASSIFICATION (2018) (0)
- GD2 CAR-T Cells exhibit strong cytolytic potency against glioma stem cells (2021) (0)
- 111 Magnetic Resonance Spectroscopic Imaging Measurement of Early Response to Vorinostat Treatment in Recurrent Glioblastoma. (2012) (0)
- USCAP 2018 Abstracts: Breast Pathology (121–337) (2018) (0)
- Abstracts from USCAP 2021: Head and Neck Pathology (635-663) (2021) (0)
- 225 Markers and Mechanisms of Disease Progression in IDH-Mutant Astrocytomas (2017) (0)
- FISH analysis of genetic markers of prognosis for high grade astrocyotmas using tissue micro-arrays from RTOG clinical trials (2003) (0)
- Clinical and neuropathologic findings in a case of posterior cortical atrophy (PCA) (2007) (0)
- CSIG-02GBM STEM CELL MIGRATION AND THE HYPOXIC MICROENVIRONMENT (2015) (0)
- TMOD-37. INTRAVITAL MONITORING DYNAMIC TUMOR MICRO-ENVIRONMENTAL EVOLUTION FOLLOWING HYPOXIA-INDUCED NECROSIS IN GLIOBLASTOMA (2019) (0)
- TMIC-48. HYPOXIC AND PERI-NECROTIC ZONES IN GLIOBLASTOMA CAUSE HIPPO-OFF SIGNALING, POTENTIALLY SUPPORTING GLIOMA STEM CELLS (2022) (0)
- Proteomic analysis of factors secreted by glioblastoma that induce endothelial tissue factor (2008) (0)
This paper list is powered by the following services:
Other Resources About Daniel Brat
What Schools Are Affiliated With Daniel Brat?
Daniel Brat is affiliated with the following schools:
